3,4,5-Trisubstituted isoxazolines (2) and isoxazoles (3) were prepared and
evaluated for their in vitro and in vivo antithrombotic efficacy. They were
compared to 3,5,5-trisubstituted isoxazolines (1) for Factor Xa selectivit
y and potency. They were also compared in an arterio-venous (A-V) shunt mod
el of thrombosis. (C) 2000 DuPont Pharmaceuticals Company. Published by Els
evier Science Ltd. All rights reserved.